Related by context. Frequent words. (Click for all words.) 72 Factor VIIa 71 liposomal formulation 71 proteasome inhibitor 71 orally bioavailable 70 RGB # 69 elotuzumab 69 IMC #B 69 Epratuzumab 69 humanized anti 69 R sorafenib tablets 69 Panzem R 68 Voreloxin 68 Drug Candidate 68 SARMs 68 PEG SN# 68 XL# [003] 68 Traficet EN 68 HCV protease inhibitor 68 CCX# 68 enzastaurin 68 Cetrorelix 68 OXi# 68 Sym# 67 Presents Positive 67 HCV protease 67 Bortezomib 67 forodesine 67 anticancer compound 67 PXD# 67 preclinical compounds 67 HGS ETR1 67 Tesetaxel 67 MEK inhibitor 67 polymerase inhibitors 67 multi kinase inhibitor 67 KRN# 66 novel anticancer 66 epothilone 66 subcutaneous formulation 66 Preclinical Data 66 Recombinant Human 66 Small Molecule 66 Cloretazine R VNP#M 66 Initiate Phase 66 MGCD# [001] 66 PSN# [002] 66 rNAPc2 66 Gemzar ® 66 SAR# [004] 66 Bicifadine 66 Guanilib 66 drug conjugate 66 chemotherapy induced neutropenia 66 Pivotal Phase III 66 Azedra 65 Completes Enrollment 65 Carfilzomib 65 Amrubicin 65 relapsed refractory multiple myeloma 65 Belinostat 65 Monoclonal Antibody 65 Aerosurf 65 TOCOSOL Paclitaxel 65 ALN TTR# 65 CYC# 65 nitric oxide donating 65 Entereg R 65 Phase III Clinical Trial 65 Perifosine 65 Aurora kinase 65 DAVANAT 65 Onalta 65 Octreotide 65 Bavituximab 65 romidepsin 64 DDP# 64 ASONEP 64 ANYARA 64 humanized antibody 64 Initiates Phase 64 Metastatic Melanoma 64 cancer immunotherapies 64 TLR9 agonist 64 SERMs 64 BCX# 64 MAXY G# 64 CR# vcMMAE 64 therapeutic monoclonal antibodies 64 humanized monoclonal antibody 64 deforolimus 64 Hybridon 64 ATL# [001] 64 ISTODAX 64 atacicept 64 KNS # 64 OncoVEX GM CSF 64 Shigamabs ® 64 Clinical Trial Results 64 immunological diseases 64 INCB# [001] 64 ALN VSP